<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05621889</url>
  </required_header>
  <id_info>
    <org_study_id>2023-11195</org_study_id>
    <nct_id>NCT05621889</nct_id>
  </id_info>
  <brief_title>Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer</brief_title>
  <official_title>Impacts of an Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model to Prevent Swallowing Disorders in Patients Treated With Chemoradiotherapy for Head and Neck Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Université du Québec à Trois-Rivières</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims to study an innovative intervention, the eG2 Intervention, developed by&#xD;
      speech-language pathologists at the Centre hospitalier de l'Université de Montréal to improve&#xD;
      therapeutic adherence and prevent dysphagia in patients treated with chemoradiotherapy for&#xD;
      head and neck cancer.&#xD;
&#xD;
      The innovation consists in offering a speech therapy intervention that is 1) virtual, 2)&#xD;
      group-based (whereas it is usually individual) and 3) involves a patient partner. This&#xD;
      intervention has the potential to improve quality of care, accessibility to services and&#xD;
      optimize health care resources.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2023</start_date>
  <completion_date type="Anticipated">January 2026</completion_date>
  <primary_completion_date type="Anticipated">January 2025</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of nasogastric tube</measure>
    <time_frame>within 6 weeks post radiation</time_frame>
    <description>To evaluate the rate of nasogastric tube placement in the acute and subacute period in patients who participated in the group intervention.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Dysphagia</condition>
  <arm_group>
    <arm_group_label>virtual group speech therapy intervention guided by a patient partner</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>virtual group speech therapy intervention guided by a patient partner</intervention_name>
    <description>virtual group speech therapy intervention guided by a patient partner</description>
    <arm_group_label>virtual group speech therapy intervention guided by a patient partner</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults ≥ 18 years of age with a diagnosis of head or neck cancer&#xD;
&#xD;
          -  Chemoradiotherapy treatments planned for curative purposes&#xD;
&#xD;
          -  Planned external radiation therapy dose of at least ≥60 Grays&#xD;
&#xD;
          -  Sufficient proficiency in French to complete self-reported questionnaires&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Remote metastases&#xD;
&#xD;
          -  Previous or planned total laryngectomy&#xD;
&#xD;
          -  Previous moderate/severe dysphagia known and/or evaluated by speech therapy&#xD;
&#xD;
          -  Diagnosis of a second synchronous cancer at the time of study enrollment&#xD;
&#xD;
          -  History of prior radiation therapy to the head and neck area&#xD;
&#xD;
          -  Have a cognitive impairment (diagnosed or suspected) that may significantly interfere&#xD;
             with participation in the intervention and various measurement procedures.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marie-Eve Caty, M.P.O., Ph.D.</last_name>
    <phone>819 376-5011</phone>
    <phone_ext>3261</phone_ext>
    <email>marie-eve.caty@uqtr.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Houda Bahig, MD PhD</last_name>
    <phone>514-890-8254</phone>
    <email>houda.bahig.med@ssss.gouv.qc.ca</email>
  </overall_contact_backup>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>November 11, 2022</study_first_submitted>
  <study_first_submitted_qc>November 11, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2022</study_first_posted>
  <last_update_submitted>April 11, 2023</last_update_submitted>
  <last_update_submitted_qc>April 11, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

